Trial Profile
Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 27 Nov 2015 New trial record